SCHEMBL5843774

SCHEMBL5843774

Nc1ccc(-c2c(F)cccc2F)cc1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.59
HSD17B10 Q99714 2/20 0.59
CYP3A4 P08684 1/20 0.59
ALOX5AP P20292 1/20 0.43
FEN1 P39748 1/20 0.43
TTR P02766 1/20 0.43
BRD4 O60885 1/20 0.42
HSD17B1 P14061 4/20 0.42
HSD17B2 P37059 4/20 0.42
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 2/20 0.39
GAA P10253 2/20 0.39
MAPT P10636 2/20 0.39
KMT2A Q03164 2/20 0.39
POLB P06746 1/20 0.39
RAB9A P51151 1/20 0.39
NEK1 Q96PY6 1/20 0.39
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
APP P05067 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5842497 0.90 CYP3A4 (0.52) ALOX15HSD17B10CYP3A4ALOX5APFEN1
SCHEMBL5843378 0.88 CYP3A4 (0.50) ALOX15HSD17B10CYP3A4ALOX5APFEN1
SCHEMBL5843815 0.80 CYP3A4 (0.53) ALOX15HSD17B10CYP3A4ALOX5APFEN1
SCHEMBL5843391 0.79 ALOX15 (0.57) ALOX15HSD17B10CYP3A4ALOX5APFEN1
SCHEMBL29878768 0.79 ALOX15 (0.57) ALOX15HSD17B10CYP3A4ALOX5APFEN1
SCHEMBL5843136 0.78 CYP3A4 (0.61) ALOX15HSD17B10CYP3A4BRD4HSD17B1
SCHEMBL29861102 0.78 HSD17B10 (0.74) ALOX15HSD17B10CYP3A4BRD4HSD17B1
SCHEMBL5843816 0.78 CYP3A4 (0.50) ALOX15HSD17B10CYP3A4ALOX5APFEN1
SCHEMBL5843520 0.78 CYP3A4 (0.50) ALOX15HSD17B10CYP3A4ALOX5APFEN1
SCHEMBL16949848 0.77 ALOX15 (0.81) ALOX15HSD17B10CYP3A4BRD4HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7122061-B2 Agents for dyeing keratin fibers, containing 4-aminobiphenyl-3-ol-derivatives WELLA AG (DE) 2006-10-17 US claimed
US-20050155160-A1 Agents for dyeing keratin fibers, containing 4-amino-biphenyl-3-ol-derivatives WELLA AKTIENGESELLSCHAFT (DE) 2005-07-21 US claimed
US-7122061-B2 Agents for dyeing keratin fibers, containing 4-aminobiphenyl-3-ol-derivatives WELLA AG (DE) 2006-10-17 US disclosed
EP-1562539-A1 AGENTS FOR DYEING KERATIN FIBERS, CONTAINING 4-AMINO-BIPHENYL-3-OL-DERIVATIVES Wella Aktiengesellschaft (DE) 2005-08-17 EP disclosed
US-20050155160-A1 Agents for dyeing keratin fibers, containing 4-amino-biphenyl-3-ol-derivatives WELLA AKTIENGESELLSCHAFT (DE) 2005-07-21 US disclosed
WO-2004041226-A1 AGENTS FOR DYEING KERATIN FIBERS, CONTAINING 4-AMINO-BIPHENYL-3-OL-DERIVATIVES WELLA AKTIENGESELLSCHAFT (DE) 2004-05-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050155160-A1 Agents for dyeing keratin fibers, containing 4-amino-biphenyl-3-ol-derivatives KRT18, CBR3, CCNB3 ALOX15 3006/4885HSD17B10 913/4885CYP3A4 835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.